Get Real Time Here
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open9.610 | Close10.080 |
| Vol / Avg.359.113K / 209.909K | Mkt Cap346.787M |
| Day Range9.610 - 10.320 | 52 Wk Range4.120 - 15.090 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.740 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-08-22 | Cantor Fitzgerald | Charles Duncan | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-07-10 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 16.00 |
| 2023-04-21 | Needham | Serge Belanger | Reiterates | Buy | Maintains | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KALV | KalVista Pharma | 5.22% | 346.8M |
| ZURA | Zura Bio | -3.37% | 287.7M |
| MGNX | Macrogenics | 3.7% | 295.5M |
| SPRY | ARS Pharmaceuticals | 4.17% | 358.4M |
| HUMA | Humacyte | -0.7% | 293.8M |
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.
Who are KalVista Pharma's (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Precigen (NASDAQ:PGEN).
What is the target price for KalVista Pharma (KALV) stock?
The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, September 8, 2023. The analyst firm set a price target for 16.00 expecting KALV to rise to within 12 months (a possible 58.73% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.08 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does KalVista Pharma (KALV) pay a dividend?
There is no dividend information for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 7, 2023.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.